| A comparison of alternative models of prescription drug utilization PV Grootendorst Econometric analysis of health data, 71-86, 2002 | 18 | 2002 |
| A comparison of alternative models of prescription drug utilization PV Grootendorst Health Economics 4 (3), 183-198, 1995 | 159 | 1995 |
| A comparison of mechanisms for setting generic drug prices A Hollis, P Grootendorst Retrieved, 2014 | 1 | 2014 |
| A comparison of mechanisms for setting generic drug prices in Canada A Hollis, P Grootendorst Journal of Generic Medicines 13 (1), 19-27, 2017 | 6 | 2017 |
| A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study PC Austin, P Grootendorst, GM Anderson Statistics in medicine 26 (4), 734-753, 2007 | 1330 | 2007 |
| A Discrete Choice Experiment (Dce) To Elicit Preferences For Attributes Of A Bedside Pharmacogenetic Test–Preliminary Results BG Bereza, P Pechlivanoglou, D Coyle, G Wells, D So, P Grootendorst, ... Value in Health 18 (7), A399, 2015 | 2 | 2015 |
| A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. P Grootendorst, D Marshall, D Pericak, N Bellamy, D Feeny, GW Torrance The Journal of rheumatology 34 (3), 534-542, 2007 | 74 | 2007 |
| A re‐examination of the impact of reference pricing on anti‐hypertensive drug plan expenditures in British Columbia P Grootendorst, D Stewart Health economics 15 (7), 735-742, 2006 | 37 | 2006 |
| A review of instrumental variables estimation of treatment effects in the applied health sciences P Grootendorst Health Services and Outcomes Research Methodology 7, 159-179, 2007 | 60 | 2007 |
| A review of the comprehensiveness of provincial drug coverage for Canadian seniors P Grootendorst, D Palfrey, D Willison, J Hurley Canadian Journal on Aging/La Revue canadienne du vieillissement 22 (1), 33-44, 2003 | 12 | 2003 |
| A Systematic Review and Meta-Analysis of the Cancer-Related and Functional Outcomes of High-Intensity Focused Ultrasound, Open Radical Prostatectomy, Robot Assisted Radical … B Toeama, E Papadimitropoulos, N Perlis, P Grootendorst, B Hamandi Urology Research and Practice 50 (1), 1, 2024 | | 2024 |
| AB1591 POLICY DRIVERS FOR MARKET PENETRATION OF ANTI-TNF BIOSIMILARS: MULTI-COUNTRY COMPARISONS W Zhang, D Guh, H Sun, A Tam, N Bansback, A Hollis, P Grootendorst, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 2029-2030, 2023 | | 2023 |
| Accord économique et commercial global entre le Canada et l'Union européenne: évaluation de l'impact économique des dispositions proposées concernant la propriété … P Grootendorst desLibris, 2011 | 1 | 2011 |
| Alendronate co-medications may limit its use. MAH Levine, P Grootendorst CLINICAL PHARMACOLOGY & THERAPEUTICS 63 (2), 197-197, 1998 | | 1998 |
| An Economic Analysis of J Moradpour, W Zhang, A Anis, P Grootendorst, A Hollis 2019 World Congress on Health Economics, 2019 | | 2019 |
| An economic analysis of the impact of reductions in generic drug rebates on community pharmacy in Canada P Grootendorst, M Rocchi, H Segal, C Gupta, MS Shim University of Tornoto: Leslie Dan Faculty of Pharmacy, 2008 | 11 | 2008 |
| An empirical analysis of milk addiction MC Auld, P Grootendorst Journal of health economics 23 (6), 1117-1133, 2004 | 190 | 2004 |
| An Empirical Analysis of Milk Addiction', Journal of Health Economics, 23 (6), November, 1117-33 MC Auld, P Grootendorst INTERNATIONAL LIBRARY OF CRITICAL WRITINGS IN ECONOMICS 223 (1), 521, 2008 | | 2008 |
| An Empirical Examination of the Determinants of Clinical Trial Activity across OECD Countries By the Pharmaceutical Industry W Zhang, O Spicer, A Hollis, A Anis, P Grootendorst 2023 World Congress on Health Economics, 2023 | | 2023 |
| An Empirical Examination of the Patented Medicine Prices Review Board Price Control Amendments on Drug Launches in Canada O Spicer, P Grootendorst Canadian Centre for Health Economics Working Papers, 2020 | 3 | 2020 |
